Title:
インスリン様成長因子(IGF-I)のレベル上昇による内臓脂肪の低下方法
Document Type and Number:
Japanese Patent JP5108303
Kind Code:
B2
Abstract:
The present invention provides methods and compositions for reducing visceral fat by administering to the subject a therapeutically effective amount of a compound that increases the bioactive serum levels of insulin-like growth factor-I (IGF-I) in the subject, thereby ameliorating negative effects of visceral obesity. The invention is useful in the treatment, prevention, or amelioration of one or more symptoms of visceral obesity or IGF-I deficiency related condition, including, for example, cardiovascular disease and the metabolic syndrome.
Inventors:
Clark Rossie.
Application Number:
JP2006524043A
Publication Date:
December 26, 2012
Filing Date:
August 20, 2004
Export Citation:
Assignee:
Tersica Incorporated
International Classes:
A61K38/22; A61K31/155; A61K31/64; A61K38/30; A61P3/04; A61P3/06; A61P43/00
Other References:
Kunitomi,M. et al.,Relationship between reduced serum IGF-I levels and accumulation of visceral fat in Japanese men,Int. J. obes.,2002年 3月,Vol.26,No.3,P.361-369
Attorney, Agent or Firm:
Naoto Uchida